Cargando…
Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes
In type 1 diabetes (T1D), β-cell loss is silent during disease progression. Methylation-sensitive quantitative real-time PCR (qPCR) of β-cell-derived DNA in the blood can serve as a biomarker of β-cell death in T1D. Amylin is highly expressed by β-cells in the islet. Here we examined whether demethy...
Autores principales: | Olsen, John A., Kenna, Lauren A., Spelios, Michael G., Hessner, Martin J., Akirav, Eitan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844136/ https://www.ncbi.nlm.nih.gov/pubmed/27111653 http://dx.doi.org/10.1371/journal.pone.0152662 |
Ejemplares similares
-
β-Cell death is decreased in women with gestational diabetes mellitus
por: Kenna, Lauren A., et al.
Publicado: (2016) -
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
por: Olsen, John A., et al.
Publicado: (2016) -
In Vitro Formation of β Cell Pseudoislets Using Islet-Derived Endothelial Cells
por: Spelios, Michael G., et al.
Publicado: (2013) -
The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
por: Ly, Han, et al.
Publicado: (2021) -
Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
por: Kiriyama, Yoshimitsu, et al.
Publicado: (2018)